ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients
Greenpep
2 other identifiers
observational
110
1 country
1
Brief Summary
Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2010
CompletedFirst Posted
Study publicly available on registry
May 19, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedApril 29, 2014
April 1, 2014
5 months
May 17, 2010
April 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
prolonged length of stay in the ICU (pLOS) more than 3 days
see above
3 days
Study Arms (1)
Critically ill patients
Eligibility Criteria
Critically ill patients of a 10 bed ICU unit
You may qualify if:
- All patients admitted to the ICU
You may not qualify if:
- Not able to understand German
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Brahms AGcollaborator
Study Sites (1)
Surgical ICU, University Hospital Zurich
Zurich, Switzerland
Related Publications (1)
Zoller B, Spanaus K, Gerster R, Fasshauer M, Stehberger PA, Klinzing S, Vergopoulos A, von Eckardstein A, Bechir M. ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU. Ann Intensive Care. 2014 Jul 8;4:19. doi: 10.1186/s13613-014-0019-7. eCollection 2014.
PMID: 25045579DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Béchir, MD
CIM
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2010
First Posted
May 19, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2010
Study Completion
February 1, 2011
Last Updated
April 29, 2014
Record last verified: 2014-04